Select year

2024 2023 2022 2021 2020 Earlier

shown/page

15

2020.06.24

Licensing Partner of Shenzhen Chipscreen Biosesciences - HUYABIO International, Receives Regulatory Approval for Chidamide Monotherapy of Adult T-cell Leukemia/lymphoma in Japan
Licensing Partner of Shenzhen Chipscreen Biosesciences - HUYABIO International, Receives Regulatory Approval for Chidamide Monotherapy of Adult T-cell Leukemia/lymphoma in Japan

2020.12.16

Chipscreen and HISUN reach a strategic cooperation
Chipscreen and HISUN reach a strategic cooperation

2020.03.24

Chipscreen Biosesciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted
Chipscreen Biosesciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted

Media contact

Media contact

（+86）0755-36993500
pr@cnzywx.com

Z6·尊龙凯时